Metastatic Breast Cancer
- 1 October 2003
- journal article
- review article
- Published by Wolters Kluwer Health
- Vol. 415, S132-S137
- https://doi.org/10.1097/01.blo.0000092981.12414.7b
Abstract
Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.Keywords
This publication has 20 references indexed in Scilit:
- Efficacy of Zoledronic Acid and Pamidronate in Breast Cancer Patients: A Comparative Analysis of Randomized Phase III TrialsAmerican Journal of Clinical Oncology, 2002
- Relationship of Serum HER-2/neu and Serum CA 15-3 in Patients with Metastatic Breast CancerClinical Chemistry, 2002
- Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol AcetateJournal of Clinical Oncology, 2001
- Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo GroupJournal of Clinical Oncology, 2001
- Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinomaCancer, 2001
- Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer PatientsJournal of Clinical Oncology, 2000
- Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.Journal of Clinical Oncology, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Clinical course and prognostic factors following bone recurrence from breast cancerBritish Journal of Cancer, 1998
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987